64 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Greenland Technologies Holding Corporation (NASDAQ:GTEC) shares climbed 180.3% to $6.56 after the company reported it will begin offering integrated electric drivetrain system to existing forklift OEM clientele to support manufacture of electric forklifts using lithium batteries.
• Summit Wireless Technologies, Inc. (NASDAQ:WISA) gained 47.4% to $3.14 after the company reported 45% year-over-year revenue growth for the third quarter. The company also said it sees more than 100% year-over-year revenue growth for Q4.
• Trxade Group, Inc. (NASDAQ:MEDS) shares gained 34.2% to $5.77 after the company entered into a solution marketing program agreement with Amazon.com Services, LLC to promote Amazon storage lockers.
• Preferred Apartment Communities, Inc. (NYSE:APTS) surged 18.6% to $7.08 after the company reported Q3 results.
• Xperi Holding Corp (NASDAQ:XPER) shares rose 18.3% to $16.48 after the company posted Q3 results.
• Infrastructure and Energy Alternatives, Inc. (NASDAQ:IEA) gained 17.7% to $11.16 after the company reported better-than-expected Q3 results and raised FY20 sales guidance.
• OPKO Health, Inc. (NASDAQ:OPK) gained 14.7% to $3.745, rebounding from Monday weakness.
• Altimmune, Inc. (NASDAQ:ALT) rose 13.8% to $8.92 after reporting a narrower-than-expected quarterly loss.
• Western Midstream Partners LP (NYSE:WES) rose 13.4% to $10.30 after the company reported better-than-expected Q3 results.
• StealthGas Inc. (NASDAQ:GASS) gained 13.3% to $2.4250.
• Luna Innovations Incorporated (NASDAQ:LUNA) surged 13.2% to $7.51 after reporting better-than-expected Q3 results.
• Sientra, Inc. (NASDAQ:SIEN) gained 13.1% to $5.37 after reporting Q3 results. The company also appointed Ron Menezes as President and Chief Executive Officer.
• Harrow Health, Inc. (NASDAQ:HROW) shares surged 11% to $5.65 after reporting Q3 results.
• Fulgent Genetics, Inc. (NASDAQ:FLGT) climbed 10.8% to $34.37 after the company reported Q3 results.
• Western Midstream Partners, LP (NYSE:WES) gained 10.8% to $10.14 following upbeat Q3 results.
• Humanigen, Inc. (NASDAQ:HGEN) rose 9.8% to $88.75 after dipping 32% on Monday. Humanigen, on Friday, announced a Cooperative Research and Development Agreement with the DoD to develop lenzilumab for COVID-19. The company also announced "positive" data from its Phase 3 trial of lenzilumab.
• TimkenSteel Corporation (NYSE:TMST) gained 9.8% to $4.72.
• Smart Sand, Inc. (NASDAQ:SND) rose 9.7% to $1.58 after the company reported better-than-expected Q3 sales.
• Tidewater Inc. (NYSE:TDW) gained 9.7% to $7.68. Tidewater released Q2 results last week.
• Inovio Pharmaceuticals, Inc. (NASDAQ:INO) rose 9.5% to $9.30 after the company posted a profit for the third quarter.
• Quad/Graphics, Inc. (NYSE:QUAD) gained 9.2% to $2.50. Quad/Graphics posted quarterly results last week.
• Stealth BioTherapeutics Corp (NASDAQ:MITO) rose 8.7% to $1.38 after Morningside Venture Investments revealed a 72.3% active stake in the company.
• Vaxart, Inc. (NASDAQ:VXRT) rose 7.6% to $3.7650 after declining 31% on Monday.
• Banco Santander, S.A. (NYSE:SAN) rose 7.4% to $2.6850 after climbing around 17% on Monday.
• Harbor Custom Development, Inc. (NASDAQ:HCDI) gained 7% to $5.26. Harbor Custom Development reported it has closed on Phase 3 sale of 66 Residential Lots at Soundview Estates in Bremerton, Washington for $7.788 million.
• Organogenesis Holdings Inc (NASDAQ:ORGO) shares rose 6.8% to $4.43 following better-than-expected Q3 results.
• Ulta Beauty, Inc. (NASDAQ:ULTA) gained 6.2% to $262.49 after the company and Target announced a strategic partnership.
• BP p.l.c. (NYSE:BP) rose 6.1% to $19.18 after gaining over 15% on Monday.
• Affimed N.V. (NASDAQ:AFMD) rose 5.5% to $3.9368 following Q3 results. Affimed and Roivant Sciences reported a licensing and strategic collaboration agreement.
• Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) rose 5.4% to $36.45 after the company posted downbeat quarterly results.
• Eli Lilly and Company (NYSE:LLY) gained 4.4% to $148.53 as the company disclosed that its monoclonal antibody treatment bamlanivimab for use against COVID-19 received an emergency use authorization from the United States Food and Drug Administration.

Check out these big penny stock gainers and losers

Losers

• InnSuites Hospitality Trust (NYSE:IHT) shares fell 33.8% to $1.9341 after surging around 82% on Monday.
• GasLog Partners LP (NYSE:GLOP) shares dipped 31.7% to $2.35 after reporting downbeat Q3 results.
• Ashford Hospitality Trust, Inc. (NYSE:AHT) fell 26.2% to $3.49.
• Arena Pharmaceuticals, Inc (NASDAQ:ARNA) shares dropped 26% to $64.67 following a decline in Q3 sales.
• Kandi Technologies Group, Inc. (NASDAQ:KNDI) fell 25% to $5.83 as the company announced entry into agreement for registered direct placement of $60 million of common stock and warrants.
• Jumia Technologies AG (NYSE:JMIA) dropped 23.3% to $12.28 after reporting Q3 earnings.
• LiveRamp Holdings, Inc. (NYSE:RAMP) fell 22.9% to $59.04 following Q2 results.
• Praxis Precision Medicines, Inc. (NASDAQ:PRAX) fell 22.2% to $27.83 after the company issued a regulatory update on PRAX-114 program. Piper Sandler initiated coverage on Praxis Precision Medicine with an Overweight rating and announced a price target of $65.
• Aurora Cannabis Inc. (NASDAQ:ACB) fell 21.8% to $8.77 after gaining over 14% on Monday.
• Medalist Diversified REIT, Inc. (NASDAQ:MDRR) fell 21.3% to $2.0062.
• Beyond Meat, Inc. (NASDAQ:BYND) shares dipped 21.1% to $118.75 after the company reported downbeat results for its third quarter. The company said it continues to experience meaningful slowdown in its Foodservice Unit.
• Voyager Therapeutics, Inc. (NASDAQ:VYGR) dipped 21% to $8.84 after the company reported Q3 earnings results. Wells Fargo and Raymond James downloaded the stock.
• MediaAlpha, Inc. (NYSE:MAX) fell 20% to $39.21.
• Yalla Group Limited (NYSE:YALA) fell 19.1% to $9.32 following Q3 results.
• Sotherly Hotels Inc. (NASDAQ:SOHO) dipped 19% to $2.0910 after surging 64% on Monday.
• Waitr Holdings Inc. (NASDAQ:WTRH) shares declined 17.5% to $2.64 after reporting Q3 results.
• Applied UV, Inc. (NASDAQ:AUVI) fell 17.4% to $5.28 as the company priced its 1.219 million share offering at $5.25 per share. Applied UV reported a non-binding letter to explore possibility of buying certain key assets of Akida, including rights to airocide system for airborne pathogen reduction for $12 million.
• Credicorp Ltd. (NYSE:BAP) shares declined 16.5% to $114.81.
• Neurocrine Biosciences, Inc. (NASDAQ:NBIX) fell 15.8% to $86.61 following weak quarterly sales.
• Exela Technologies, Inc (NASDAQ:XELA) fell 14.1% to $0.3701 after the company reported Q3 results and issued weak sales forecast.
• GreenSky, Inc. (NASDAQ:GSKY) dipped 13.8% to $3.74 following weak Q3 results.
• Vital Farms, Inc. (NASDAQ:VITL) dropped 13.8% to $30.54 after the company reported Q3 results and announced a proposed secondary public offering of 5 million shares of common stock.
• Repay Holdings Corporation (NASDAQ:RPAY) tumbled 13.6% to $22.90 following Q3 results.
• Nautilus, Inc. (NYSE:NLS) fell 12.4% to $19.16 after the company reported Q3 results and also issued FY20 sales guidance. Nautilus also filed for mixed shelf offering of up to $100 million, according to SEC filing.
• Tilray, Inc. (NASDAQ:TLRY) dipped 12.4% to $8.85 after the company reported worse-than-expected Q3 sales.
• Sundial Growers Inc. (NASDAQ:SNDL) fell 11.8% to $0.4041 after jumping 83% on Monday. Sundial Growers is expected to report quarterly earnings on November 11. Sundial Growers highlighted expansion into edible market and will collaborate with Choklat.
• Tattooed Chef, Inc. (NASDAQ:TTCF) dropped 11.8% to $17.70 after the company posted Q3 results.
• Novavax, Inc. (NASDAQ:NVAX) fell 10% to $81.26 after reporting Q3 results.
• Carnival Corporation & Plc (NYSE:CUK) fell 9.9% to $15.14 after jumping 41% on Monday.
• Ameri Holdings, Inc. (NASDAQ:AMRH) fell 8.4% to $1.3466 after surging 14% on Monday.
• Akerna Corp. (NASDAQ:KERN) fell 8.3% to $3.97 after gaining over 5% on Monday.
• TherapeuticsMD Inc (NASDAQ:TXMD) fell 7.7% to $1.4025 after the company announced an underwritten public offering of its common stock.
• The RealReal, Inc. (NASDAQ:REAL) shares fell 5.7% to $15.33 after reporting downbeat quarterly earnings.